Neumora Therapeutics Q3 Earnings Preview Shows EPS Estimate of $(0.20)

Neumora Therapeutics is scheduled to report Q3'26 results on November 4. EPS is estimated at $(0.20); the release time is not specified in the headline, while the body says 7:00 a.m. ET.